Conversion of antimalarial drug artemisinin to a new series of tricyclic 1,2,4-trioxanes

Organic Letters

Volumn 9, Issue 21, 2007, Pages 4327-4329

  Singh, Chandan ^a   Chaudhary, Sandeep ^a   Kanchan, Rani ^a   Puri, Sunil K ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; ARTEMISININ DERIVATIVE; HETEROCYCLIC COMPOUND;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANTIMALARIALS; ARTEMISININS; HETEROCYCLIC COMPOUNDS; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 35548961043     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol701887x     Document Type: Article

References (22)

1. C.D.R.I. communication no. 7162.
2. (a) Klayman, D. L. Science 1985, 228, 1049-1055.
3. (b) Luo, X. D.; Shen, C. C. Med. Res. Rev. 1987, 7, 29-52.
4. (c) Cumming, J. N.; Ploypradith, P.; Posner, G. H. Adv. Pharmacol. 1997, 37, 253-297.
5. (d) Bhattacharya, A. K.; Sharma, R. P. Heterocycles 1999, 51, 1651-1681.
6. (e) Borstnik, K.; Paik, I.; Shapiro, T. A.; Posner; G. H. Int. J. Parasitol. 2002, 32, 1661-1667.
7. (f) Ploypradith, P. Acta Trop. 2004, 89, 329-342.
8. (g) O'Neill, P. M.; Posner, G. H. J. Med. Chem 2004, 47, 2945-2964.
9. (h) Tang, Y.; Dong, Y.; Vennerstrom, J. L. Med. Res. Rev. 2004, 24, 425-448.
10. (i) Jefford, C. W. Drug Discovery Today 2007, /2, 487-494.
11. Meshnick, S. R.; Taylor, T. E.; Kamchonwongpaisan, S. Microbiol. Rev. 1996, 60, 301-315.
12. Butler, A. R.; Yu, Y. L. Chem. Soc. Rev. 1992, 2/, 85-90.
13. (a) Hindley, S.; Ward, S. A.; Storr, R. C.; Searle, N. L.; Bray, P. G.; Park, B. K.; Davies, J.; O'Neill, P. M. J. Med. Chem. 2002, 45, 1052-1063.
14. (b) Avery, M. A.; Alvim-Gaston, M.; Vroman, J. A.; Wu, B.; Ager, A.; Peters, W.; Robinson, B. L.; Charman, W. J. Med. Chem. 2002, 45, 4321-4335.
15. (c) Posner, G H.; Paik, I.-H.; Sur, S.; McRiner, A. J.; Borstnik, K.; Xie, S.; Shapiro, T. A. J. Med. Chem. 2003, 46, 1060-1065.
16. (d) Grellepois, F.; Chorki, F.; Ourevitch, M.; Chameau, S.; Grellier, P.; Mcintosh, K. A.; Charman, W. N.; Pradines, B.; Crousse, B.; Bonnet-delpon, D.; Begue, J. P. J. Med. Chem. 2004, 47, 1423-1433.
17. (e) Paik, I.-H.; Xie, S.; Shapiro, T. A.; Labonte, T.; Narducci Sarjeant, A. A.; Baege, A. C.; Posner, G. H. J. Med. Chem. 2006, 49 (9), 2731-2734.
18. (f) Posner, G. H.; Paik, I.-H.; Chang, W.; Borstnik, K.; Sinishtaj, S.; Rosenthal, A. S.; Shapiro, T. A. J. Med. Chem. 2007, 50 (10), 2516-2519.
19. (a) Posner, G. H.; Oh, C. H.; Gerena, L.; Milhous, W. K. J. Med. Chem. 1992, 35, 2459.
20. (b) Posner, G. H.; Oh, C. H.; Webster, K.; Ager, A. L., Jr.; Rossan, R. N. Am. J. Trop. Med. Hyg. 1994, 50, 522-526.
21. Singh, C.; Kanchan, R. Indian J. Chem. 1999, 38B, 1368-1370.
22. For an in vivo antimalarial efficacy test procedure, see: Singh, C.; Chaudhary, S.; Puri, S. K. J. Med. Chem. 2006, 49 (24), 7227-7233.